世界の膵臓がん分子診断市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Pancreatic Cancer Molecular Diagnostics Market Size, Status and Forecast 2021-2027

• レポートコード：QFJ1-4649
• 出版社/出版日：QYResearch / 2021年6月
※2024年版があります。お問い合わせください。
• レポート形態：英文、PDF、95ページ
• 納品方法：Eメール（納期：3日）
• 産業分類：医療

• 販売価格（消費税別）

Single User	￥585,000 (USD3,900)	▷ お問い合わせ
Multi User	￥877,500 (USD5,850)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

レポート概要

QYResearch社発行の本調査レポートでは、膵臓がん分子診断の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（PCR、FISH、DNAシーケンシング、ジーンチップ）、用途別市場規模（臨床診断、薬物スクリーニング、研究）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、企業情報などをまとめております。
・市場概要
・膵臓がん分子診断の市場動向
・企業の競争状況、市場シェア
・膵臓がん分子診断の種類別市場規模と予測2016-2027（PCR、FISH、DNAシーケンシング、ジーンチップ）
・膵臓がん分子診断の用途別市場規模と予測2016-2027（臨床診断、薬物スクリーニング、研究）
・膵臓がん分子診断の北米市場規模2016-2027（アメリカ、カナダ）
・膵臓がん分子診断の欧州市場規模2016-2027（ドイツ、フランス、イギリス等）
・膵臓がん分子診断のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等）
・膵臓がん分子診断の中南米市場規模2016-2027（メキシコ、ブラジル）
・膵臓がん分子診断の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等）
・主要企業情報（Tellgen、Mole、Genetronhealth、Berryoncology、Gene+、Helixgen、Annoroad、Topgen、Geneis）
・結論

A molecular approach for diagnosing pancreatic cancer

Market Analysis and Insights: Global Pancreatic Cancer Molecular Diagnostics Market
The global Pancreatic Cancer Molecular Diagnostics market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Pancreatic Cancer Molecular Diagnostics market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Pancreatic Cancer Molecular Diagnostics market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Pancreatic Cancer Molecular Diagnostics market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Pancreatic Cancer Molecular Diagnostics market.

Global Pancreatic Cancer Molecular Diagnostics Scope and Market Size
Pancreatic Cancer Molecular Diagnostics market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Pancreatic Cancer Molecular Diagnostics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
PCR
FISH
DNA Sequencing
Gene Chip

Segment by Application
Clinical Diagnosis
Drug Screening
Research

By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Tellgen
Mole
Genetronhealth
Berryoncology
Gene+
Helixgen
Annoroad
Topgen
Geneis

レポート目次

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Pancreatic Cancer Molecular Diagnostics Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 PCR
1.2.3 FISH
1.2.4 DNA Sequencing
1.2.5 Gene Chip
1.3 Market by Application
1.3.1 Global Pancreatic Cancer Molecular Diagnostics Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Clinical Diagnosis
1.3.3 Drug Screening
1.3.4 Research
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Pancreatic Cancer Molecular Diagnostics Market Perspective (2016-2027)
2.2 Pancreatic Cancer Molecular Diagnostics Growth Trends by Regions
2.2.1 Pancreatic Cancer Molecular Diagnostics Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Pancreatic Cancer Molecular Diagnostics Historic Market Share by Regions (2016-2021)
2.2.3 Pancreatic Cancer Molecular Diagnostics Forecasted Market Size by Regions (2022-2027)
2.3 Pancreatic Cancer Molecular Diagnostics Industry Dynamic
2.3.1 Pancreatic Cancer Molecular Diagnostics Market Trends
2.3.2 Pancreatic Cancer Molecular Diagnostics Market Drivers
2.3.3 Pancreatic Cancer Molecular Diagnostics Market Challenges
2.3.4 Pancreatic Cancer Molecular Diagnostics Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Pancreatic Cancer Molecular Diagnostics Players by Revenue
3.1.1 Global Top Pancreatic Cancer Molecular Diagnostics Players by Revenue (2016-2021)
3.1.2 Global Pancreatic Cancer Molecular Diagnostics Revenue Market Share by Players (2016-2021)
3.2 Global Pancreatic Cancer Molecular Diagnostics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Pancreatic Cancer Molecular Diagnostics Revenue
3.4 Global Pancreatic Cancer Molecular Diagnostics Market Concentration Ratio
3.4.1 Global Pancreatic Cancer Molecular Diagnostics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Pancreatic Cancer Molecular Diagnostics Revenue in 2020
3.5 Pancreatic Cancer Molecular Diagnostics Key Players Head office and Area Served
3.6 Key Players Pancreatic Cancer Molecular Diagnostics Product Solution and Service
3.7 Date of Enter into Pancreatic Cancer Molecular Diagnostics Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Pancreatic Cancer Molecular Diagnostics Breakdown Data by Type
4.1 Global Pancreatic Cancer Molecular Diagnostics Historic Market Size by Type (2016-2021)
4.2 Global Pancreatic Cancer Molecular Diagnostics Forecasted Market Size by Type (2022-2027)

5 Pancreatic Cancer Molecular Diagnostics Breakdown Data by Application
5.1 Global Pancreatic Cancer Molecular Diagnostics Historic Market Size by Application (2016-2021)
5.2 Global Pancreatic Cancer Molecular Diagnostics Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Pancreatic Cancer Molecular Diagnostics Market Size (2016-2027)
6.2 North America Pancreatic Cancer Molecular Diagnostics Market Size by Type
6.2.1 North America Pancreatic Cancer Molecular Diagnostics Market Size by Type (2016-2021)
6.2.2 North America Pancreatic Cancer Molecular Diagnostics Market Size by Type (2022-2027)
6.2.3 North America Pancreatic Cancer Molecular Diagnostics Market Size by Type (2016-2027)
6.3 North America Pancreatic Cancer Molecular Diagnostics Market Size by Application
6.3.1 North America Pancreatic Cancer Molecular Diagnostics Market Size by Application (2016-2021)
6.3.2 North America Pancreatic Cancer Molecular Diagnostics Market Size by Application (2022-2027)
6.3.3 North America Pancreatic Cancer Molecular Diagnostics Market Size by Application (2016-2027)
6.4 North America Pancreatic Cancer Molecular Diagnostics Market Size by Country
6.4.1 North America Pancreatic Cancer Molecular Diagnostics Market Size by Country (2016-2021)
6.4.2 North America Pancreatic Cancer Molecular Diagnostics Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada

7 Europe
7.1 Europe Pancreatic Cancer Molecular Diagnostics Market Size (2016-2027)
7.2 Europe Pancreatic Cancer Molecular Diagnostics Market Size by Type
7.2.1 Europe Pancreatic Cancer Molecular Diagnostics Market Size by Type (2016-2021)
7.2.2 Europe Pancreatic Cancer Molecular Diagnostics Market Size by Type (2022-2027)
7.2.3 Europe Pancreatic Cancer Molecular Diagnostics Market Size by Type (2016-2027)
7.3 Europe Pancreatic Cancer Molecular Diagnostics Market Size by Application
7.3.1 Europe Pancreatic Cancer Molecular Diagnostics Market Size by Application (2016-2021)
7.3.2 Europe Pancreatic Cancer Molecular Diagnostics Market Size by Application (2022-2027)
7.3.3 Europe Pancreatic Cancer Molecular Diagnostics Market Size by Application (2016-2027)
7.4 Europe Pancreatic Cancer Molecular Diagnostics Market Size by Country
7.4.1 Europe Pancreatic Cancer Molecular Diagnostics Market Size by Country (2016-2021)
7.4.2 Europe Pancreatic Cancer Molecular Diagnostics Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Pancreatic Cancer Molecular Diagnostics Market Size (2016-2027)
8.2 Asia-Pacific Pancreatic Cancer Molecular Diagnostics Market Size by Type
8.2.1 Asia-Pacific Pancreatic Cancer Molecular Diagnostics Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Pancreatic Cancer Molecular Diagnostics Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Pancreatic Cancer Molecular Diagnostics Market Size by Type (2016-2027)
8.3 Asia-Pacific Pancreatic Cancer Molecular Diagnostics Market Size by Application
8.3.1 Asia-Pacific Pancreatic Cancer Molecular Diagnostics Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Pancreatic Cancer Molecular Diagnostics Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Pancreatic Cancer Molecular Diagnostics Market Size by Application (2016-2027)
8.4 Asia-Pacific Pancreatic Cancer Molecular Diagnostics Market Size by Region
8.4.1 Asia-Pacific Pancreatic Cancer Molecular Diagnostics Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Pancreatic Cancer Molecular Diagnostics Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Pancreatic Cancer Molecular Diagnostics Market Size (2016-2027)
9.2 Latin America Pancreatic Cancer Molecular Diagnostics Market Size by Type
9.2.1 Latin America Pancreatic Cancer Molecular Diagnostics Market Size by Type (2016-2021)
9.2.2 Latin America Pancreatic Cancer Molecular Diagnostics Market Size by Type (2022-2027)
9.2.3 Latin America Pancreatic Cancer Molecular Diagnostics Market Size by Type (2016-2027)
9.3 Latin America Pancreatic Cancer Molecular Diagnostics Market Size by Application
9.3.1 Latin America Pancreatic Cancer Molecular Diagnostics Market Size by Application (2016-2021)
9.3.2 Latin America Pancreatic Cancer Molecular Diagnostics Market Size by Application (2022-2027)
9.3.3 Latin America Pancreatic Cancer Molecular Diagnostics Market Size by Application (2016-2027)
9.4 Latin America Pancreatic Cancer Molecular Diagnostics Market Size by Country
9.4.1 Latin America Pancreatic Cancer Molecular Diagnostics Market Size by Country (2016-2021)
9.4.2 Latin America Pancreatic Cancer Molecular Diagnostics Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Pancreatic Cancer Molecular Diagnostics Market Size (2016-2027)
10.2 Middle East & Africa Pancreatic Cancer Molecular Diagnostics Market Size by Type
10.2.1 Middle East & Africa Pancreatic Cancer Molecular Diagnostics Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Pancreatic Cancer Molecular Diagnostics Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Pancreatic Cancer Molecular Diagnostics Market Size by Type (2016-2027)
10.3 Middle East & Africa Pancreatic Cancer Molecular Diagnostics Market Size by Application
10.3.1 Middle East & Africa Pancreatic Cancer Molecular Diagnostics Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Pancreatic Cancer Molecular Diagnostics Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Pancreatic Cancer Molecular Diagnostics Market Size by Application (2016-2027)
10.4 Middle East & Africa Pancreatic Cancer Molecular Diagnostics Market Size by Country
10.4.1 Middle East & Africa Pancreatic Cancer Molecular Diagnostics Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Pancreatic Cancer Molecular Diagnostics Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Tellgen
11.1.1 Tellgen Company Details
11.1.2 Tellgen Business Overview
11.1.3 Tellgen Pancreatic Cancer Molecular Diagnostics Introduction
11.1.4 Tellgen Revenue in Pancreatic Cancer Molecular Diagnostics Business (2016-2021)
11.1.5 Tellgen Recent Development
11.2 Mole
11.2.1 Mole Company Details
11.2.2 Mole Business Overview
11.2.3 Mole Pancreatic Cancer Molecular Diagnostics Introduction
11.2.4 Mole Revenue in Pancreatic Cancer Molecular Diagnostics Business (2016-2021)
11.2.5 Mole Recent Development
11.3 Genetronhealth
11.3.1 Genetronhealth Company Details
11.3.2 Genetronhealth Business Overview
11.3.3 Genetronhealth Pancreatic Cancer Molecular Diagnostics Introduction
11.3.4 Genetronhealth Revenue in Pancreatic Cancer Molecular Diagnostics Business (2016-2021)
11.3.5 Genetronhealth Recent Development
11.4 Berryoncology
11.4.1 Berryoncology Company Details
11.4.2 Berryoncology Business Overview
11.4.3 Berryoncology Pancreatic Cancer Molecular Diagnostics Introduction
11.4.4 Berryoncology Revenue in Pancreatic Cancer Molecular Diagnostics Business (2016-2021)
11.4.5 Berryoncology Recent Development
11.5 Gene+
11.5.1 Gene+ Company Details
11.5.2 Gene+ Business Overview
11.5.3 Gene+ Pancreatic Cancer Molecular Diagnostics Introduction
11.5.4 Gene+ Revenue in Pancreatic Cancer Molecular Diagnostics Business (2016-2021)
11.5.5 Gene+ Recent Development
11.6 Helixgen
11.6.1 Helixgen Company Details
11.6.2 Helixgen Business Overview
11.6.3 Helixgen Pancreatic Cancer Molecular Diagnostics Introduction
11.6.4 Helixgen Revenue in Pancreatic Cancer Molecular Diagnostics Business (2016-2021)
11.6.5 Helixgen Recent Development
11.7 Annoroad
11.7.1 Annoroad Company Details
11.7.2 Annoroad Business Overview
11.7.3 Annoroad Pancreatic Cancer Molecular Diagnostics Introduction
11.7.4 Annoroad Revenue in Pancreatic Cancer Molecular Diagnostics Business (2016-2021)
11.7.5 Annoroad Recent Development
11.8 Topgen
11.8.1 Topgen Company Details
11.8.2 Topgen Business Overview
11.8.3 Topgen Pancreatic Cancer Molecular Diagnostics Introduction
11.8.4 Topgen Revenue in Pancreatic Cancer Molecular Diagnostics Business (2016-2021)
11.8.5 Topgen Recent Development
11.9 Geneis
11.9.1 Geneis Company Details
11.9.2 Geneis Business Overview
11.9.3 Geneis Pancreatic Cancer Molecular Diagnostics Introduction
11.9.4 Geneis Revenue in Pancreatic Cancer Molecular Diagnostics Business (2016-2021)
11.9.5 Geneis Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Pancreatic Cancer Molecular Diagnostics Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of PCR
Table 3. Key Players of FISH
Table 4. Key Players of DNA Sequencing
Table 5. Key Players of Gene Chip
Table 6. Global Pancreatic Cancer Molecular Diagnostics Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Pancreatic Cancer Molecular Diagnostics Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 8. Global Pancreatic Cancer Molecular Diagnostics Market Size by Regions (2016-2021) & (US$ Million)
Table 9. Global Pancreatic Cancer Molecular Diagnostics Market Share by Regions (2016-2021)
Table 10. Global Pancreatic Cancer Molecular Diagnostics Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 11. Global Pancreatic Cancer Molecular Diagnostics Market Share by Regions (2022-2027)
Table 12. Pancreatic Cancer Molecular Diagnostics Market Trends
Table 13. Pancreatic Cancer Molecular Diagnostics Market Drivers
Table 14. Pancreatic Cancer Molecular Diagnostics Market Challenges
Table 15. Pancreatic Cancer Molecular Diagnostics Market Restraints
Table 16. Global Pancreatic Cancer Molecular Diagnostics Revenue by Players (2016-2021) & (US$ Million)
Table 17. Global Pancreatic Cancer Molecular Diagnostics Market Share by Players (2016-2021)
Table 18. Global Top Pancreatic Cancer Molecular Diagnostics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Pancreatic Cancer Molecular Diagnostics as of 2020)
Table 19. Ranking of Global Top Pancreatic Cancer Molecular Diagnostics Companies by Revenue (US$ Million) in 2020
Table 20. Global 5 Largest Players Market Share by Pancreatic Cancer Molecular Diagnostics Revenue (CR5 and HHI) & (2016-2021)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Pancreatic Cancer Molecular Diagnostics Product Solution and Service
Table 23. Date of Enter into Pancreatic Cancer Molecular Diagnostics Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Pancreatic Cancer Molecular Diagnostics Market Size by Type (2016-2021) (US$ Million)
Table 26. Global Pancreatic Cancer Molecular Diagnostics Revenue Market Share by Type (2016-2021)
Table 27. Global Pancreatic Cancer Molecular Diagnostics Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 28. Global Pancreatic Cancer Molecular Diagnostics Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 29. Global Pancreatic Cancer Molecular Diagnostics Market Size Share by Application (2016-2021) & (US$ Million)
Table 30. Global Pancreatic Cancer Molecular Diagnostics Revenue Market Share by Application (2016-2021)
Table 31. Global Pancreatic Cancer Molecular Diagnostics Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 32. Global Pancreatic Cancer Molecular Diagnostics Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 33. North America Pancreatic Cancer Molecular Diagnostics Market Size by Type (2016-2021) (US$ Million)
Table 34. North America Pancreatic Cancer Molecular Diagnostics Market Size by Type (2022-2027) & (US$ Million)
Table 35. North America Pancreatic Cancer Molecular Diagnostics Market Size by Application (2016-2021) (US$ Million)
Table 36. North America Pancreatic Cancer Molecular Diagnostics Market Size by Application (2022-2027) & (US$ Million)
Table 37. North America Pancreatic Cancer Molecular Diagnostics Market Size by Country (2016-2021) & (US$ Million)
Table 38. North America Pancreatic Cancer Molecular Diagnostics Market Size by Country (2022-2027) & (US$ Million)
Table 39. Europe Pancreatic Cancer Molecular Diagnostics Market Size by Type (2016-2021) (US$ Million)
Table 40. Europe Pancreatic Cancer Molecular Diagnostics Market Size by Type (2022-2027) & (US$ Million)
Table 41. Europe Pancreatic Cancer Molecular Diagnostics Market Size by Application (2016-2021) (US$ Million)
Table 42. Europe Pancreatic Cancer Molecular Diagnostics Market Size by Application (2022-2027) & (US$ Million)
Table 43. Europe Pancreatic Cancer Molecular Diagnostics Market Size by Country (2016-2021) & (US$ Million)
Table 44. Europe Pancreatic Cancer Molecular Diagnostics Market Size by Country (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Pancreatic Cancer Molecular Diagnostics Market Size by Type (2016-2021) (US$ Million)
Table 46. Asia-Pacific Pancreatic Cancer Molecular Diagnostics Market Size by Type (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Pancreatic Cancer Molecular Diagnostics Market Size by Application (2016-2021) (US$ Million)
Table 48. Asia-Pacific Pancreatic Cancer Molecular Diagnostics Market Size by Application (2022-2027) & (US$ Million)
Table 49. Asia-Pacific Pancreatic Cancer Molecular Diagnostics Market Size by Region (2016-2021) & (US$ Million)
Table 50. Asia-Pacific Pancreatic Cancer Molecular Diagnostics Market Size by Region (2022-2027) & (US$ Million)
Table 51. Latin America Pancreatic Cancer Molecular Diagnostics Market Size by Type (2016-2021) (US$ Million)
Table 52. Latin America Pancreatic Cancer Molecular Diagnostics Market Size by Type (2022-2027) & (US$ Million)
Table 53. Latin America Pancreatic Cancer Molecular Diagnostics Market Size by Application (2016-2021) (US$ Million)
Table 54. Latin America Pancreatic Cancer Molecular Diagnostics Market Size by Application (2022-2027) & (US$ Million)
Table 55. Latin America Pancreatic Cancer Molecular Diagnostics Market Size by Country (2016-2021) & (US$ Million)
Table 56. Latin America Pancreatic Cancer Molecular Diagnostics Market Size by Country (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Pancreatic Cancer Molecular Diagnostics Market Size by Type (2016-2021) (US$ Million)
Table 58. Middle East & Africa Pancreatic Cancer Molecular Diagnostics Market Size by Type (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Pancreatic Cancer Molecular Diagnostics Market Size by Application (2016-2021) (US$ Million)
Table 60. Middle East & Africa Pancreatic Cancer Molecular Diagnostics Market Size by Application (2022-2027) & (US$ Million)
Table 61. Middle East & Africa Pancreatic Cancer Molecular Diagnostics Market Size by Country (2016-2021) & (US$ Million)
Table 62. Middle East & Africa Pancreatic Cancer Molecular Diagnostics Market Size by Country (2022-2027) & (US$ Million)
Table 63. Tellgen Company Details
Table 64. Tellgen Business Overview
Table 65. Tellgen Pancreatic Cancer Molecular Diagnostics Product
Table 66. Tellgen Revenue in Pancreatic Cancer Molecular Diagnostics Business (2016-2021) & (US$ Million)
Table 67. Tellgen Recent Development
Table 68. Mole Company Details
Table 69. Mole Business Overview
Table 70. Mole Pancreatic Cancer Molecular Diagnostics Product
Table 71. Mole Revenue in Pancreatic Cancer Molecular Diagnostics Business (2016-2021) & (US$ Million)
Table 72. Mole Recent Development
Table 73. Genetronhealth Company Details
Table 74. Genetronhealth Business Overview
Table 75. Genetronhealth Pancreatic Cancer Molecular Diagnostics Product
Table 76. Genetronhealth Revenue in Pancreatic Cancer Molecular Diagnostics Business (2016-2021) & (US$ Million)
Table 77. Genetronhealth Recent Development
Table 78. Berryoncology Company Details
Table 79. Berryoncology Business Overview
Table 80. Berryoncology Pancreatic Cancer Molecular Diagnostics Product
Table 81. Berryoncology Revenue in Pancreatic Cancer Molecular Diagnostics Business (2016-2021) & (US$ Million)
Table 82. Berryoncology Recent Development
Table 83. Gene+ Company Details
Table 84. Gene+ Business Overview
Table 85. Gene+ Pancreatic Cancer Molecular Diagnostics Product
Table 86. Gene+ Revenue in Pancreatic Cancer Molecular Diagnostics Business (2016-2021) & (US$ Million)
Table 87. Gene+ Recent Development
Table 88. Helixgen Company Details
Table 89. Helixgen Business Overview
Table 90. Helixgen Pancreatic Cancer Molecular Diagnostics Product
Table 91. Helixgen Revenue in Pancreatic Cancer Molecular Diagnostics Business (2016-2021) & (US$ Million)
Table 92. Helixgen Recent Development
Table 93. Annoroad Company Details
Table 94. Annoroad Business Overview
Table 95. Annoroad Pancreatic Cancer Molecular Diagnostics Product
Table 96. Annoroad Revenue in Pancreatic Cancer Molecular Diagnostics Business (2016-2021) & (US$ Million)
Table 97. Annoroad Recent Development
Table 98. Topgen Company Details
Table 99. Topgen Business Overview
Table 100. Topgen Revenue in Pancreatic Cancer Molecular Diagnostics Business (2016-2021) & (US$ Million)
Table 101. Topgen Recent Development
Table 102. Geneis Company Details
Table 103. Geneis Business Overview
Table 104. Geneis Pancreatic Cancer Molecular Diagnostics Product
Table 105. Geneis Revenue in Pancreatic Cancer Molecular Diagnostics Business (2016-2021) & (US$ Million)
Table 106. Geneis Recent Development
Table 107. Research Programs/Design for This Report
Table 108. Key Data Information from Secondary Sources
Table 109. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Pancreatic Cancer Molecular Diagnostics Market Share by Type: 2020 VS 2027
Figure 2. PCR Features
Figure 3. FISH Features
Figure 4. DNA Sequencing Features
Figure 5. Gene Chip Features
Figure 6. Global Pancreatic Cancer Molecular Diagnostics Market Share by Application: 2020 VS 2027
Figure 7. Clinical Diagnosis Case Studies
Figure 8. Drug Screening Case Studies
Figure 9. Research Case Studies
Figure 10. Pancreatic Cancer Molecular Diagnostics Report Years Considered
Figure 11. Global Pancreatic Cancer Molecular Diagnostics Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 12. Global Pancreatic Cancer Molecular Diagnostics Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 13. Global Pancreatic Cancer Molecular Diagnostics Market Share by Regions: 2020 VS 2027
Figure 14. Global Pancreatic Cancer Molecular Diagnostics Market Share by Regions (2022-2027)
Figure 15. Global Pancreatic Cancer Molecular Diagnostics Market Share by Players in 2020
Figure 16. Global Top Pancreatic Cancer Molecular Diagnostics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Pancreatic Cancer Molecular Diagnostics as of 2020
Figure 17. The Top 10 and 5 Players Market Share by Pancreatic Cancer Molecular Diagnostics Revenue in 2020
Figure 18. Global Pancreatic Cancer Molecular Diagnostics Revenue Market Share by Type (2016-2021)
Figure 19. Global Pancreatic Cancer Molecular Diagnostics Revenue Market Share by Type (2022-2027)
Figure 20. North America Pancreatic Cancer Molecular Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 21. North America Pancreatic Cancer Molecular Diagnostics Market Share by Type (2016-2027)
Figure 22. North America Pancreatic Cancer Molecular Diagnostics Market Share by Application (2016-2027)
Figure 23. North America Pancreatic Cancer Molecular Diagnostics Market Share by Country (2016-2027)
Figure 24. United States Pancreatic Cancer Molecular Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Canada Pancreatic Cancer Molecular Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Europe Pancreatic Cancer Molecular Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Europe Pancreatic Cancer Molecular Diagnostics Market Share by Type (2016-2027)
Figure 28. Europe Pancreatic Cancer Molecular Diagnostics Market Share by Application (2016-2027)
Figure 29. Europe Pancreatic Cancer Molecular Diagnostics Market Share by Country (2016-2027)
Figure 30. Germany Pancreatic Cancer Molecular Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. France Pancreatic Cancer Molecular Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. U.K. Pancreatic Cancer Molecular Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Italy Pancreatic Cancer Molecular Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Russia Pancreatic Cancer Molecular Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Nordic Pancreatic Cancer Molecular Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Asia-Pacific Pancreatic Cancer Molecular Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Asia-Pacific Pancreatic Cancer Molecular Diagnostics Market Share by Type (2016-2027)
Figure 38. Asia-Pacific Pancreatic Cancer Molecular Diagnostics Market Share by Application (2016-2027)
Figure 39. Asia-Pacific Pancreatic Cancer Molecular Diagnostics Market Share by Region (2016-2027)
Figure 40. China Pancreatic Cancer Molecular Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Japan Pancreatic Cancer Molecular Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. South Korea Pancreatic Cancer Molecular Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Southeast Asia Pancreatic Cancer Molecular Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. India Pancreatic Cancer Molecular Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Australia Pancreatic Cancer Molecular Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Latin America Pancreatic Cancer Molecular Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Latin America Pancreatic Cancer Molecular Diagnostics Market Share by Type (2016-2027)
Figure 48. Latin America Pancreatic Cancer Molecular Diagnostics Market Share by Application (2016-2027)
Figure 49. Latin America Pancreatic Cancer Molecular Diagnostics Market Share by Country (2016-2027)
Figure 50. Mexico Pancreatic Cancer Molecular Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Brazil Pancreatic Cancer Molecular Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Middle East & Africa Pancreatic Cancer Molecular Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Middle East & Africa Pancreatic Cancer Molecular Diagnostics Market Share by Type (2016-2027)
Figure 54. Middle East & Africa Pancreatic Cancer Molecular Diagnostics Market Share by Application (2016-2027)
Figure 55. Middle East & Africa Pancreatic Cancer Molecular Diagnostics Market Share by Country (2016-2027)
Figure 56. Turkey Pancreatic Cancer Molecular Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Saudi Arabia Pancreatic Cancer Molecular Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. UAE Pancreatic Cancer Molecular Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. Tellgen Revenue Growth Rate in Pancreatic Cancer Molecular Diagnostics Business (2016-2021)
Figure 60. Mole Revenue Growth Rate in Pancreatic Cancer Molecular Diagnostics Business (2016-2021)
Figure 61. Genetronhealth Revenue Growth Rate in Pancreatic Cancer Molecular Diagnostics Business (2016-2021)
Figure 62. Berryoncology Revenue Growth Rate in Pancreatic Cancer Molecular Diagnostics Business (2016-2021)
Figure 63. Gene+ Revenue Growth Rate in Pancreatic Cancer Molecular Diagnostics Business (2016-2021)
Figure 64. Helixgen Revenue Growth Rate in Pancreatic Cancer Molecular Diagnostics Business (2016-2021)
Figure 65. Annoroad Revenue Growth Rate in Pancreatic Cancer Molecular Diagnostics Business (2016-2021)
Figure 66. Topgen Revenue Growth Rate in Pancreatic Cancer Molecular Diagnostics Business (2016-2021)
Figure 67. Geneis Revenue Growth Rate in Pancreatic Cancer Molecular Diagnostics Business (2016-2021)
Figure 68. Bottom-up and Top-down Approaches for This Report
Figure 69. Data Triangulation
Figure 70. Key Executives Interviewed

以下、関連資料のご紹介

世界の喉頭がん分子診断市場規模・現状・予測（2021年-2027年）

Global Laryngeal Cancer Molecular Diagnostics Market Size, Status and Forecast 2021-2027
QFJ1-4412 2021年6月 85Pages
QYResearch社発行の本調査レポートでは、喉頭がん分子診断の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（PCR、FISH、DNAシーケンシング、ジーンチップ）、用途別市場規模（臨床診断、薬物スクリーニング、研究）、主要地域別市場規模（北米、...

世界の膀胱がん分子病理学診断市場規模・現状・予測（2021年-2027年）

Global Bladder Cancer Molecular Diagnostics Market Size, Status and Forecast 2021-2027
QFJ1-3914 2021年6月 98Pages
QYResearch社発行の本調査レポートでは、膀胱がん分子病理学診断の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（PCR、FISH、DNAシーケンシング、ジーンチップ）、用途別市場規模（臨床診断、薬物スクリーニング、研究所）、主要地域別市場規模...

世界の甲状腺がん分子診断市場規模・現状・予測（2021年-2027年）

Global Thyroid Cancer Molecular Diagnostics Market Size, Status and Forecast 2021-2027
QFJ1-4953 2021年6月 109Pages
QYResearch社発行の本調査レポートでは、甲状腺がん分子診断の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（PCR、FISH、DNAシーケンシング、ジーンチップ）、用途別市場規模（臨床診断、薬物スクリーニング、研究）、主要地域別市場規模（北米...

世界の胃がん分子診断市場規模・現状・予測（2021年-2027年）

Global Stomach Cancer Molecular Diagnostics Market Size, Status and Forecast 2021-2027
QFJ1-4909 2021年6月 107Pages
QYResearch社発行の本調査レポートでは、胃がん分子診断の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（PCR、FISH、DNAシーケンシング、ジーンチップ）、用途別市場規模（臨床診断、薬物スクリーニング、研究）、主要地域別市場規模（北米、ア...

世界の肺がん分子診断市場規模・現状・予測（2021年-2027年）

Global Lung Cancer Molecular Diagnostics Market Size, Status and Forecast 2021-2027
QFJ1-4443 2021年6月 108Pages
QYResearch社発行の本調査レポートでは、肺がん分子診断の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（PCR、FISH、DNAシーケンシング、ジーンチップ）、用途別市場規模（臨床診断、薬物スクリーニング、研究）、主要地域別市場規模（北米、ア...

世界の転移性膵がん治療市場規模・現状・予測（2021年-2027年）

Global Metastatic Pancreatic Cancer Treatment Market Size, Status and Forecast 2021-2027
QFJ1-4499 2021年6月 99Pages
QYResearch社発行の本調査レポートでは、転移性膵がん治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（化学療法、標的療法、その他）、用途別市場規模（外分泌、内分泌）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、イン...

世界の口腔がん分子診断市場規模・現状・予測（2021年-2027年）

Global Oral Cancer Molecular Diagnosis Market Size, Status and Forecast 2021-2027
QFJ1-4622 2021年6月 86Pages
QYResearch社発行の本調査レポートでは、口腔がん分子診断の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（PCR、FISH、DNAシーケンシング、ジーンチップ）、用途別市場規模（臨床診断、薬物スクリーニング、研究）、主要地域別市場規模（北米、...

世界の胆嚢がん分子診断市場規模・現状・予測（2021年-2027年）

Global Molecular Diagnosis of Gallbladder Cancer Market Size, Status and Forecast 2021-2027
QFJ1-4516 2021年6月 85Pages
QYResearch社発行の本調査レポートでは、胆嚢がん分子診断の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（PCR、FISH、DNAシーケンシング、ジーンチップ）、用途別市場規模（臨床診断、薬物スクリーニング、研究）、主要地域別市場規模（北米、...

世界の黒色腫分子診断市場規模・現状・予測（2021年-2027年）

Global Melanoma Molecular Diagnostics Market Size, Status and Forecast 2021-2027
QFJ1-4488 2021年6月 105Pages
QYResearch社発行の本調査レポートでは、黒色腫分子診断の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（PCR、FISH、DNAシーケンシング、ジーンチップ）、用途別市場規模（臨床診断、薬物スクリーニング、研究）、主要地域別市場規模（北米、ア...

世界の前がん病変分子診断市場規模・現状・予測（2021年-2027年）

Global Precancer Molecular Diagnostics Market Size, Status and Forecast 2021-2027
QFJ1-4742 2021年6月 107Pages
QYResearch社発行の本調査レポートでは、前がん病変分子診断の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（PCR、FISH、DNAシーケンシング、ジーンチップ）、用途別市場規模（臨床診断、薬物スクリーニング、研究）、主要地域別市場規模（北米...

世界の喉頭がん分子診断市場規模・現状・予測（2021年-2027年） A molecular approach for diagnosing laryngeal cancer Market Analysis and Insights: Global Laryngeal Cancer Molecular Diagnostics Market The global Laryngeal Cancer Molecular Diagnostics market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 202…
世界の膀胱がん分子病理学診断市場規模・現状・予測（2021年-2027年） A molecular approach for diagnosing bladder cancer Market Analysis and Insights: Global Bladder Cancer Molecular Diagnostics Market The global Bladder Cancer Molecular Diagnostics market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027…
世界の甲状腺がん分子診断市場規模・現状・予測（2021年-2027年） A molecular approach for diagnosing thyroid cancer Market Analysis and Insights: Global Thyroid Cancer Molecular Diagnostics Market The global Thyroid Cancer Molecular Diagnostics market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027…
世界の胃がん分子診断市場規模・現状・予測（2021年-2027年） A molecular approach for diagnosing stomach cancer Market Analysis and Insights: Global Stomach Cancer Molecular Diagnostics Market The global Stomach Cancer Molecular Diagnostics market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027…
世界の口腔がん分子診断市場規模・現状・予測（2021年-2027年） A molecular approach for diagnosing oral cancer Market Analysis and Insights: Global Oral Cancer Molecular Diagnosis Market The global Oral Cancer Molecular Diagnosis market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With indust…